We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Sandusky, OH -- May 6, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today highlighted that the upcoming CBD Nutraceutical Sales Rollout Presentation scheduled for tomorrow...
Sandusky, OH -- May 5, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today confirmed a CBD Nutraceutical Sales Rollout Presentation scheduled this Friday, May 7, 2021. Last...
Sandusky, OH -- May 3, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today announced plans to present the company’s CBD Nutraceutical Sales Rollout Plan this Friday, May 7...
Sandusky, OH -- April 13, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today released a management update on the company’s ongoing CBD Pharmaceutical Development Program...
April 12, 2021 -- InvestorsHub NewsWire -- via AmericanBulls.com/PAOG PAO Group, Inc. (USOTC: PAOG) Our system’s recommendation today is to BUY...
Sandusky, OH -- April 8, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today announced a management update on the company’s ongoing CBD Pharmaceutical Development Program...
Sandusky, OH -- March 16, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today released details on the company’s nutraceutical developments initiative following last...
Sandusky, OH -- March 10, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (OTC Pink: PAOG) today encouraged all interested to save the date, Tuesday, March 16, 2021, when PAOG will...
Sandusky, OH -- March 8, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today announced initiating the development of its new nutraceutical, RELAX-RX, targeting the anxiety and...
Sandusky, OH -- February 3, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc. (USOTC: PAOG) today announced the company anticipates reporting an estimated $50,000 in revenue for Q4 2020. The...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 25000 | 1.0E-6 | CS |
4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 985880 | 1.0E-6 | CS |
12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 499330 | 1.0E-6 | CS |
26 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 422020 | 1.0E-6 | CS |
52 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 367465 | 1.05E-6 | CS |
156 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 228989 | 1.404E-5 | CS |
260 | -0.006299 | -99.9841269841 | 0.0063 | 0.0123 | 1.0E-6 | 3808944 | 0.00173917 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions